Danica Walsh

Dr. Danica Walsh

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
DWDanica Walsh
Danica Walsh
TLTom Livinghouse
Tom Livinghouse
DGDarla M. Goeres
Darla M. Goeres
MMMadelyn Mettler
Madelyn Mettler
PSPhilip Stewart
Philip Stewart
Biofilm-forming bacteria present formidable challenges across diverse settings, and there is a need for new antimicrobial agents that are both environmentally acceptable and relatively potent against microorganisms in the biofilm state. The antimicrobial activity of three naturally occurring, low molecular weight, phenols, and their derivatives were evaluated against planktonic and biofilm Staphylococcus epidermidis and Pseudomonas aeruginosa. The structure activity relationships of eugenol, thymol, carvacrol, and their corresponding 2- and 4-allyl, 2-methallyl, and 2- and 4-n-propyl derivatives were evaluated. Allyl derivatives showed a consistent increased potency with both killing and inhibiting planktonic cells but they exhibited a decrease in potency against biofilms. This result underscores the importance of using biofilm assays to develop structure-activity relationships when the end target is biofilm.

28 January 2019 in Biomedical Physics & Engineering Express
Verified
Journal Article
Open access
PDF file
ABAaron David Benjamin
Aaron David Benjamin
RAReha Abbasi
Reha Abbasi
MOMadison Owens
Madison Owens
RORobert J Olsen
Robert J Olsen
DWDanica Walsh
Danica Walsh
JWJames Nolen Wilking
James Nolen Wilking

13 March 2020 in ACS Omega
Verified
Journal Article
Open access
DWDanica Walsh
Danica Walsh
TLTom Livinghouse
Tom Livinghouse
Gregory DurlingGregory Durling
Gregory Durling
YCYenny Chase-Bayless
Yenny Chase-Bayless
AAAdrienne D. Arnold
Adrienne D. Arnold
PSPhilip S. Stewart
Philip S. Stewart
The recalcitrance exhibited by microbial biofilms to conventional disinfectants has motivated the development of new chemical strategies to control and eradicate biofilms. The activities of several small phenolic compounds and their trichloromethylsulfenyl ester derivatives were evaluated against planktonic cells and mature biofilms of Staphylococcus epidermidis and Pseudomonas aeruginosa. Some of the phenolic parent compounds are well-studied constituents of plant essential oils, for example, eugenol, menthol, carvacrol, and thymol. The potency of sulfenate ester derivatives was markedly and consistently increased toward both planktonic cells and biofilms. The mean fold difference between the parent and derivative minimum inhibitory concentration against planktonic cells was 44 for S. epidermidis and 16 for P. aeruginosa. The mean fold difference between the parent and derivative biofilm eradication concentration for 22 tested compounds against both S. epidermidis and P. aeruginosa was 3. This work demonstrates the possibilities of a new class of biofilm-targeting disinfectants deploying a sulfenate ester functional group to increase the antimicrobial potency toward microorganisms in biofilms.

Verified
Journal Article
Open access
PDF file
EHElizabeth I. Harper
Elizabeth I. Harper
MSMichael D. Siroky
Michael D. Siroky
THTyvette Hilliard
Tyvette Hilliard
GDGena M. Dominique
Gena M. Dominique
CHCatherine Hammond
Catherine Hammond
MSM. Sharon Stack
M. Sharon Stack
Ovarian cancer is the sixth leading cause of cancer-related death in women, and both occurrence and mortality are increased in women over the age of 60. There are documented age-related changes in the ovarian cancer microenvironment that have been shown to create a permissive metastatic niche, including the formation of advanced glycation end products, or AGEs, that form crosslinks between collagen molecules. Small molecules that disrupt AGEs, known as AGE breakers, have been examined in other diseases, but their efficacy in ovarian cancer has not been evaluated. The goal of this pilot study is to target age-related changes in the tumor microenvironment with the long-term aim of improving response to therapy in older patients. Here, we show that AGE breakers have the potential to change the omental collagen structure and modulate the peritoneal immune landscape, suggesting a potential use for AGE breakers in the treatment of ovarian cancer.

26 August 2020 in Chemical Biology & Drug Design
Verified
Journal Article
Open access
PDF file
DWDanica Walsh
Danica Walsh
TLTom Livinghouse
Tom Livinghouse
Gregory DurlingGregory Durling
Gregory Durling
AAAdrienne D. Arnold
Adrienne D. Arnold
WBWhitney Brasier
Whitney Brasier
PSPhilip S. Stewart
Philip S. Stewart
Prodrugs are pharmacologically attenuated derivatives of drugs that undergo bioconversion into the active compound once reaching the targeted site, thereby maximizing their efficiency. This strategy has been implemented in pharmaceuticals to overcome obstacles related to absorption, distribution, and metabolism, as well as with intracellular dyes to ensure concentration within cells. In this study, we provide the first examples of a prodrug strategy that can be applied to simple phenolic antimicrobials to increase their potency against mature biofilms. The addition of (acetoxy)methyl iminodiacetate groups increases the otherwise modest potency of simple phenols. Biofilm‐forming bacteria exhibit a heightened tolerance toward antimicrobial agents, thereby accentuating the need for new antibiotics as well as those, which incorporate novel delivery strategies to enhance activity toward biofilms.

8 January 2026 in RSC Medicinal Chemistry
Verified
Journal Article
Open access
PDF file
DWDanica Walsh
Danica Walsh
RHRawia Hamid
Rawia Hamid
TGTim Giele
Tim Giele
NRNorbert Reiling
Norbert Reiling
MRMatthias Rottmann
Matthias Rottmann
AHAnna Hirsch
Anna Hirsch
Simplified amide IspE inhibitors restore potency against Klebsiella pneumoniae and Escherichia coli , offering synthetically accessible antibacterial hits.